glp-1 colon cancer receptor agonists—the class of drugs behind Ozempic, Wegovy, and Mounjaro—may do more than regulate blood sugar and weight. In an analysis of more than 6,800 patients across Missed our Instagram Live on
Description
If you have been avoiding GLP-1 weight loss drugs because of a fear of needles, you are not alone
Multiple studies highlight its potential applications in prevention
The wild card-to-uncertainty about GLP-1 meds growth will be reimbursement: spending will continue to accelerate with upside if more widely reimbursed, IQVIA projects
We identify only lst-1 and sygl-1, two of a number of previously reported targets, as likely the sole primary mRNA transcriptional targets of GLP-1 signaling that promote the germline stem cell fate
From CVS to Sinopharm, see which global giants lead by workforce size.
Learn which liver enzyme tests matter, what your results mean, and how to monitor safely as you lose weight.
